Immunotherapy Drugs Market by Type of Drug, Size, Share| MarketsandMarkets™
According to the new market research report “Immunotherapy Drugs Market by Type of Drugs
(Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area
(Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals),
Region (North America, Asia-Pacific) – Global Forecast to 2021“,
published by MarketsandMarkets™,The global immunotherapy drugs market is
projected...
Immunotherapy Drugs Market : Geographic Snapshot And Key Market Leaders
The global immunotherapy drugs market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.
Market Growth Drivers:
1 Increasing Adoption of Targeted Therapy Over Traditional Therapy
2 Emergence of Biosimilars
3 Increasing Demand for Mabs
4 High Prevalence Rate of Lifestyle Diseases
5 Fast Track and Orphan...
Immunotherapy Drugs Market Leading Players and Growth Startegies
Immunotherapy Drugs Market, by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific)-Global Forecast to 2021
F. Hoffmann-La Roche AG (Switzerland), Johnson & Johnson (U.S.), and Abbvie, Inc. (U.S.) are the leading players in the global immunotherapy drugs...
Immunotherapy Drugs Market : Key Growth Drivers, Restraints, & Opportunities
The global Immunotherapy Drugs Market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. North America is expected to account for largest share in the immunotherapy drugs market, by region in 2016. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of...